Gelsolin (BioAegis Therapeutics) | Interleukin Related interleukin-related.com

Product Name :
Gelsolin (BioAegis Therapeutics)

Search keywords :
Gelsolin

drugId :
null

Target Vo:
Actin

Target Vo Short Name :
Actin

Moa_Name:
Actin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Brigham and Women’s Hospital Inc

Active Company_Name :
Bioaegis Therapeutics Inc

Active Indication_Name:
Decompression Sickness

In Active Indication_Name:
Wounds and Injuries

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Acetyl-Histone H3 (Lys14) Rabbit mAb Epigenetic Reader Domain
CK18 Antibody In stock
FOXO4 Antibody: FOXO4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to FOXO4. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts